{"url_path":"/sec/rmtg/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","accession_number":"0001213900-26-066838","cik":"0001760026","ticker":"RMTG","issuer_name":"Regenerative Medical Technology Group Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","primary_entity_key":"0001760026","primary_entity_name":"Regenerative Medical Technology Group Inc."},"word_count":87,"has_tables":true,"body_markdown":"**Item 1. Legal Proceedings**\n\n \n\nTo the Company’s knowledge, there is no\naction, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization\nor body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting\nour Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or\ndirectors in their capacities as such, in which an adverse decision could have a material adverse effect."}